Market Overview:
The global recycled polyester fiber market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for sustainable and environment-friendly products. Additionally, the growing awareness about the benefits of using recycled polyester fiber is also contributing to the growth of this market. The recycled polyester fiber market can be segmented on the basis of type, application, and region. On the basis of type, this market can be segmented into prokinetic drugs, gastric antisecretory drugs, and others. The prokinetic drugs segment is expected to grow at a higher CAGR during the forecast period as compared to other segments owing to its growing demand in various applications such as hospitals and drugstores across different regions worldwide.
Product Definition:
Recycled Polyester Fiber is a fiber made from recycled polyester materials. It is important because it helps reduce environmental waste and can be reused to create new products.
Prokinetic Drugs:
Prokinetic drugs are used to treat conditions associated with abnormal movement of the GI tract. They promote movements through neural stimulation and electrical stimulation of the gastrointestinal tract. Prokinetic drugs delay gastric emptying time, thus increasing its bioavailability in the small intestine, which results in enhanced nutrient absorption.
Gastric Antisecretory Drugs:
Gastric antisecretory drugs are used to reduce stomach acid secretions. They work by reducing the production of gastric acids that cause heartburn or acid indigestion. The most commonly used drug class for this purpose is histamine H2 receptor antagonists, including cimetidine, ranitidine and famotidine. Other drugs in this class include nizatide and zantac (Pantoprazole).
Application Insights:
Based on application, the global market is segmented into hospitals, drugstores and others. Hospitals were the largest application segment in 2017 and are expected to maintain their dominance over the forecast period. Recycled polyester fibers have a high demand from hospitals as they help reduce wrinkles and keep skin looking young by reducing excess oil production. They also help reduce puffiness under eyes which improves facial features.
The drugstore industry is another lucrative sector for recycled polyester fiber manufacturers as these products assist people who cannot tolerate any form of aspirin or other painkillers due to allergies or other reasons. Moreover, they can be used by patients with diabetes mellitus type 2 as it does not affect blood sugar levels like regular acetylsalicylic acid (ASA) drugs do.
Regional Analysis:
Asia Pacific is expected to be the largest regional market over the forecast period. The growth of this region can be attributed to rising product demand from various end-use industries, such as medical and healthcare, automotive, construction and consumer goods. China is estimated to remain a key manufacturing hub for global DRP manufacturers owing to low production costs coupled with easy availability of raw materials.
The growing population in Asia Pacific has led to an increase in demand for medicines across this region; however, stringent government regulations regarding drug quality are hampering market growth in some countries such as India and Japan. This may lead manufacturers operating within these regions towards investing more heavily in R&D activities aimed at developing high-quality products that meet international standards while remaining competitively priced within their respective markets.
North America emerged as the second major regional market followed by Europe due its increasing use for prokinetic drugs along with other applications including paints & coatings.
Growth Factors:
- Increasing awareness about the benefits of recycled polyester fiber among consumers.
- Growing demand for sustainable and environment-friendly products.
- Rising popularity of recycled polyester fiber in the apparel industry.
- Proliferation of online retail platforms that promote sustainable fashion products made from recycled materials. 5) Development of innovative technologies for recycling post-consumer plastics into high quality polyester fibers
Scope Of The Report
Report Attributes
Report Details
Report Title
Recycled Polyester Fiber Market Research Report
By Type
Prokinetic Drugs, Gastric Antisecretory Drugs, Others
By Application
Hospitals, Drugstores
By Companies
Bayer, Sumitomo, Cadila Pharmaceuticals, Teva, Johnson & Johnson, Pfizer, Sanofi, AstraZeneca, Jiangsu Aosaikang Pharma, Eisai, Kyowa Kirin Pharmaceuticals, Hanmi Pharm
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Recycled Polyester Fiber Market Report Segments:
The global Recycled Polyester Fiber market is segmented on the basis of:
Types
Prokinetic Drugs, Gastric Antisecretory Drugs, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Drugstores
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer
- Sumitomo
- Cadila Pharmaceuticals
- Teva
- Johnson & Johnson
- Pfizer
- Sanofi
- AstraZeneca
- Jiangsu Aosaikang Pharma
- Eisai
- Kyowa Kirin Pharmaceuticals
- Hanmi Pharm
Highlights of The Recycled Polyester Fiber Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Prokinetic Drugs
- Gastric Antisecretory Drugs
- Others
- By Application:
- Hospitals
- Drugstores
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Recycled Polyester Fiber Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Recycled polyester fiber is made from post-consumer plastic bottles and other plastics that have been recycled. It is a type of synthetic fiber that can be used in products such as clothing, insulation, and carpeting.
Some of the major players in the recycled polyester fiber market are Bayer, Sumitomo, Cadila Pharmaceuticals, Teva, Johnson & Johnson, Pfizer, Sanofi, AstraZeneca, Jiangsu Aosaikang Pharma, Eisai, Kyowa Kirin Pharmaceuticals, Hanmi Pharm.
The recycled polyester fiber market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Recycled Polyester Fiber Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Recycled Polyester Fiber Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Recycled Polyester Fiber Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Recycled Polyester Fiber Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Recycled Polyester Fiber Market Size & Forecast, 2020-2028
4.5.1 Recycled Polyester Fiber Market Size and Y-o-Y Growth
4.5.2 Recycled Polyester Fiber Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Prokinetic Drugs
5.2.2 Gastric Antisecretory Drugs
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Drugstores
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Recycled Polyester Fiber Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Recycled Polyester Fiber Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Prokinetic Drugs
9.6.2 Gastric Antisecretory Drugs
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Drugstores
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Prokinetic Drugs
10.6.2 Gastric Antisecretory Drugs
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Drugstores
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Prokinetic Drugs
11.6.2 Gastric Antisecretory Drugs
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Drugstores
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Prokinetic Drugs
12.6.2 Gastric Antisecretory Drugs
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Drugstores
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Prokinetic Drugs
13.6.2 Gastric Antisecretory Drugs
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Drugstores
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Recycled Polyester Fiber Market: Competitive Dashboard
14.2 Global Recycled Polyester Fiber Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer
14.3.2 Sumitomo
14.3.3 Cadila Pharmaceuticals
14.3.4 Teva
14.3.5 Johnson & Johnson
14.3.6 Pfizer
14.3.7 Sanofi
14.3.8 AstraZeneca
14.3.9 Jiangsu Aosaikang Pharma
14.3.10 Eisai
14.3.11 Kyowa Kirin Pharmaceuticals
14.3.12 Hanmi Pharm
